Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
06/2003
06/26/2003US20030119896 Chondrogenesis promoters and indolin-2-one derivatives
06/26/2003US20030119895 Anticancer agents
06/26/2003US20030119893 Non-selective beta-blocker with a vasodilating component
06/26/2003US20030119876 Compounds for the treatment of protozoal diseases
06/26/2003US20030119858 Conformationally constrained compounds as pharmaceutical agents
06/26/2003US20030119857 Pyrimidinyl methyl indole derivatives with antibacterial activity
06/26/2003US20030119839 Indalones and other fused heterocylce-ones
06/26/2003US20030119834 Angiogenesis inhibitors; 3-alkyl-4-one quinazoline derivatives
06/26/2003US20030119833 Treating cardiovascular diseases
06/26/2003US20030119830 Monocyte chemoattractant protein-1 inhibitor compounds
06/26/2003US20030119820 Substituted indoles
06/26/2003US20030119819 Anticancer agents
06/26/2003US20030119814 Novel prodrugs of N-H bond-containing compounds and methods of making thereof
06/26/2003US20030119803 In particular N-epsilon-amino acid substituted L-lysine derivatives possessing aspartyl protease inhibitory properties.
06/26/2003US20030119788 N-cyanomethyl carbonamides and sulfonamides which are cysteine protease, particularly cathepsin K, inhibitors
06/26/2003US20030119749 Novel compounds possessing antibacterial, antifungal or antitumor activity
06/26/2003US20030119748 Use for treatment of inflammatory, autoimmune and neurodegenerative diseases, for the prevention of ischemic injury.
06/26/2003US20030119721 Electrophilic ketones for the treatment of herpesvirus infections
06/26/2003US20030119060 Drug screening, development; controlling solvent selection
06/26/2003US20030119022 Alkylation, crosslinking
06/26/2003US20030118078 Apparatuses and methods for creating and testing pre-formulations and systems for same
06/26/2003US20030116497 Apparatuses and methods for creating and testing pre-formulations and systems for same
06/26/2003CA2470307A1 Protein kinase inhibitors
06/26/2003CA2468880A1 Tetrahydrocarbazole derivatives as ligands for g-protein coupled receptors (gpcr)
06/26/2003CA2468413A1 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
06/25/2003EP1321471A1 Method for synthesis of perindopril and its pharmaceutically acceptable salts
06/25/2003EP1321452A2 Process for the preparation of optically active amines or salts thereof
06/25/2003EP1320540A2 Peptidomimetic protease inhibitors
06/25/2003EP1320523A2 Branched chain amino acid-dependent aminotransferase inhibitors and their use in the treatment of neurodegenerative diseases
06/25/2003EP1320522A2 Compositions and methods of the use thereof achiral analogues of cc-1065 and the duocarmycins
06/25/2003EP1320520A1 Sulfonylguanidine
06/25/2003EP0906094B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl]propyl amides
06/25/2003CN1426412A Novel compounds
06/25/2003CN1426408A Pyrimidinyl methyl indole derivatives with antibacterial activity
06/25/2003CN1426406A Process for producing optically active sulfoxide devivative'
06/25/2003CN1426394A Novel compounds
06/25/2003CN1426393A Novel compounds
06/25/2003CN1426391A Polyamine analogues as cytotoxic agents
06/25/2003CN1425651A Tegaserod maleate-water crystal
06/24/2003US6583294 Process for the preparation of an indole derivative
06/24/2003US6583286 Method for hydrogenating unsaturated heterocyclic compounds
06/24/2003US6583245 Polymeric stabilizers having low polydispersity
06/24/2003US6583183 Substituted n-phenyl-n-fused-benzyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
06/24/2003US6583177 Leukotriene B4 antagonist compounds and method for treatment
06/24/2003US6583173 Useful as anticoagulants in mammals; inhibitors of factor Xa
06/24/2003US6583169 N-phenyl benzimidazolecarboxamide and N-phenyl indolecarboxamide derivatives
06/24/2003US6583168 Sulfonated diarylrhodamine dyes
06/24/2003US6583145 Thio-oxindole derivatives
06/24/2003US6583144 Piperazine substituted isoquinoline, 1,3-benzoxazine, or 1,3-benzothiazine derivatives; inhibitors against the biosynthesis of triglycerides and secretion of apolipoprotein b and treatment of hyperlipidemia
06/24/2003CA2272014C N-aryl/heteroaryl-substituted heterocycles
06/24/2003CA2067074C N'-substituted n-amino-3,4,5,6,-tetrafluorophthalimides, and processes for their preparation
06/19/2003WO2003051092A1 [5] helicene AND dibenzofluorene MATERIALS FOR USE IN ORGANIC LIGHT EMITTING DEVICES
06/19/2003WO2003050099A1 Phenylalkynes
06/19/2003WO2003050086A1 2, 7 - substituted carbazoles and oligomers, polymers and co-polymers thereof
06/19/2003WO2003049702A2 Vanilloid receptor ligands and their use in treatments
06/19/2003WO2003049698A2 Substituted hydrazones as inhibitors of cyclooxygenase-2
06/19/2003WO2003028650A3 Benzimidazolidinone derivatives as muscarinic agents
06/19/2003US20030114710 Optical information recording medium and novel immonium compound
06/19/2003US20030114685 Processes for preparing calcium salt forms of statins
06/19/2003US20030114684 Process for the preparation of an indole derivative
06/19/2003US20030114683 Novel 1,3-dihydro-2h-indol-2-one derivatives and their use as ligands for v1b and v1a arginine-vasopressin receptors
06/19/2003US20030114521 Oxamic acids and derivatives as thyroid receptor ligands
06/19/2003US20030114516 Novel immunotherapeutic agents
06/19/2003US20030114513 Use of isatin derivatives as ion channel activating agents
06/19/2003US20030114508 Fused imidazolium derivatives
06/19/2003US20030114463 Tetrahydroindolone and purine derivatives linked to arylpiperazines
06/19/2003US20030114457 2- [5- (5-carbamimidoyl-1H-heteroaryl)-6-hydroxybiphenyl-3-yl]-succinic acid derivatives as factor viia inhibitors
06/19/2003US20030114454 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
06/19/2003US20030114448 Inhibitors of factor Xa
06/19/2003US20030114442 Reducing concentration of blood lipoproteins
06/19/2003US20030114441 Heterocyclic anti-epileptogenic agents and methods of use thereof
06/19/2003US20030114440 Compositions and methods of treatment for conditions responsive to testosterone elevation
06/19/2003US20030113644 Charge transport compound containing bis(3-formylcarbazolyl)-1,1'-(sulfonyldi-4, 1-phenylene)bis-hydrazones
06/19/2003US20030113643 Electrophotographic organophotoreceptors with novel charge transport materials
06/19/2003US20030113505 Capable of recording information by laser irradiation
06/19/2003US20030113132 Charge transport compounds of hydrazone substituted carbazole derivatives, a charge generating compound and electroconductive substrate
06/19/2003US20030111107 Spiro compounds and their use
06/19/2003CA2470106A1 2, 7 - substituted carbazoles and oligomers, polymers and co-polymers thereof
06/19/2003CA2469893A1 Phenylalkynes
06/19/2003CA2469709A1 Substituted hydrazones as inhibitors of cyclooxygenase-2
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/18/2003EP1319668A1 Method for synthesis of (2S,3aS,7aS)-1-((S)-alanyl)-octahydro-1H-indole-2-carboxylic acid derivatives and use in the synthesis of perindopril
06/18/2003EP1319047A1 Cyanine dyes
06/18/2003EP1319006A1 Tetrahydrocarbazoles, a process for the preparation of those compounds, and the use thereof
06/18/2003EP1318980A2 Hydroxamate derivatives useful as deacetylase inhibitors
06/18/2003EP1318978A2 N-acylsulfonamide apoptosis promoters
06/18/2003EP1318976A2 Substituted aminopropoxyaryl derivatives useful as agonists for lxr
06/18/2003EP1318974A2 Resorcinol derivatives
06/18/2003EP1255757B1 Amino acid derivatives and use thereof as nep, ace and ece inhibitors
06/18/2003EP1115704B1 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes
06/18/2003EP0815859B1 Intimal thickening inhibitors
06/18/2003CN1425003A Methylation of indole compounds from dimethyl carbonate
06/18/2003CN1425002A Pyrrolidine and piperidine derivatives and their use for treatment of neurodegenerative disorders
06/18/2003CN1424312A Specific indole compound and its preparation and use in treating and preventing cancers
06/18/2003CN1424311A Process for separating and refining indole
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/17/2003US6579897 For therapy of cancer, arthritis, diabetic retinopathy, restinosis, hepatic cirrhosis, atherosclerosis, angiogenesis, glomerulonephritis, diabetic nephropathy, thrombic microangiopathy syndromes, transplant rejection
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/17/2003US6579823 Group 8-10 metal complex comprising a bidentate or variable denticity ligand; polymerization of olefins
06/17/2003US6579718 For detecting and quantifying peptides, polypeptides and proteins; sensitive, facile and does not require use of organic solvents
1 ... 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 ... 458